Hong Seog Seo Selected Research

Coronary Vasospasm (Coronary Artery Vasospasm)

5/2022	Impact of drug-eluting stent-associated coronary artery spasm on 3-year clinical outcomes: A propensity score matching analysis.
4/2018	Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study.
3/2018	Five-year major clinical outcomes according to severity of coronary artery spasm as assessed by intracoronary acetylcholine provocation test.
1/2018	The association of chronic air pollutants with coronary artery spasm, vasospastic angina, and endothelial dysfunction.
1/2018	Impact of alcohol drinking on acetylcholine-induced coronary artery spasm in Korean populations.
7/2017	Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis.
1/2017	Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
1/2017	Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm.
10/2016	Impact of old age on clinical and angiographic characteristics of coronary artery spasm as assessed by acetylcholine provocation test.
6/2014	Diabetes mellitus is not a risk factor for coronary artery spasm as assessed by an intracoronary acetylcholine provocation test: angiographic and clinical characteristics of 986 patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Seog Seo Research Topics

Disease

41	Myocardial Infarction 01/2022 - 06/2002
27	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 04/2010
19	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 04/2006
16	Inflammation (Inflammations) 01/2022 - 01/2011
14	Coronary Vasospasm (Coronary Artery Vasospasm) 05/2022 - 09/2012
14	Hypertension (High Blood Pressure) 01/2022 - 01/2004
11	Diabetes Mellitus 01/2021 - 09/2012
11	Atrial Fibrillation 12/2020 - 04/2011
9	Thrombosis (Thrombus) 09/2020 - 09/2007
8	Spasm (Spasms) 01/2017 - 10/2007
6	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2014
6	Atherosclerosis 01/2020 - 01/2010
6	Chest Pain (Chest Pains) 06/2014 - 02/2007
5	Insulin Resistance 04/2022 - 02/2013
5	Heart Failure 01/2022 - 11/2014
5	Stroke (Strokes) 09/2020 - 09/2016
4	Obesity 01/2022 - 06/2007
4	Death (Near-Death Experience) 09/2020 - 04/2010
4	Atherosclerotic Plaque (Atheroma) 01/2020 - 01/2007
4	Dyslipidemias (Dyslipidemia) 01/2020 - 06/2010
4	Infarction (Infarctions) 04/2018 - 06/2002
4	Pathologic Constriction (Stenosis) 03/2018 - 01/2005
4	ST Elevation Myocardial Infarction 12/2017 - 06/2009
4	Essential Hypertension 10/2016 - 01/2004
3	Hemorrhage 09/2020 - 02/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 03/2010
3	Stable Angina 01/2020 - 04/2006
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2018 - 01/2004
3	Hypercholesterolemia 01/2017 - 11/2007
2	Heart Diseases (Heart Disease) 01/2021 - 11/2006
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 02/2007
2	Vascular Diseases (Vascular Disease) 01/2018 - 07/2005
2	Coronary Stenosis (Coronary Artery Stenosis) 07/2017 - 01/2005
2	Cardiac Arrhythmias (Arrythmia) 06/2015 - 04/2011
2	Chronic Limb-Threatening Ischemia 04/2015 - 03/2015
2	Acute Coronary Syndrome 01/2014 - 04/2006
2	Hyperlipidemias (Hyperlipidemia) 09/2012 - 01/2011
1	Cataract (Cataracts) 01/2022
1	Arteritis 01/2021

Drug/Important Bio-Agent (IBA)

19	omega-Chloroacetophenone (Mace)IBA 10/2021 - 07/2017
19	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2018 - 10/2007
14	CholesterolIBA 01/2022 - 11/2007
11	C-Reactive ProteinIBA 01/2021 - 05/2008
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2022 - 01/2010
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2011
7	Antihypertensive Agents (Antihypertensives)IBA 06/2020 - 06/2005
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2021 - 01/2011
5	LDL CholesterolIBA 01/2022 - 01/2010
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2014
5	AdiponectinIBA 01/2019 - 01/2004
5	Triglycerides (Triacylglycerol)IBA 07/2016 - 11/2007
4	Clopidogrel (Plavix)FDA Link 09/2020 - 10/2006
4	oxidized low density lipoproteinIBA 01/2020 - 11/2007
4	LipidsIBA 01/2020 - 09/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 02/2007
4	Sirolimus (Rapamycin)FDA Link 10/2014 - 09/2007
4	Phenobarbital (Luminal)FDA Link 06/2014 - 01/2005
3	Uric Acid (Urate)IBA 01/2021 - 03/2010
3	Atorvastatin (Lipitor)FDA Link 01/2021 - 11/2007
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 06/2014
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 02/2007
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2019 - 01/2017
3	Lipoprotein(a)IBA 01/2018 - 07/2005
3	fimasartanIBA 01/2017 - 10/2016
3	Amlodipine (Norvasc)FDA LinkGeneric 10/2016 - 06/2005
3	CarrageenanIBA 07/2016 - 01/2014
2	Insulin (Novolin)FDA Link 04/2022 - 01/2020
2	SterolsIBA 01/2021 - 01/2016
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2020 - 07/2016
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 03/2010
2	Mannose ReceptorIBA 01/2020 - 11/2016
2	Apolipoproteins E (ApoE)IBA 01/2019 - 01/2017
2	NitratesIBA 04/2018 - 01/2017
2	pitavastatin (itavastatin)FDA Link 01/2018 - 11/2007
2	Air Pollutants (Pollutants, Air)IBA 01/2018 - 06/2017
2	Angiotensin Receptor AntagonistsIBA 12/2017 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2017 - 01/2016
2	N 30IBA 10/2014 - 10/2011
2	Everolimus FDA Link 10/2014 - 09/2012
2	zotarolimusIBA 09/2012 - 12/2009
2	Heparin (Liquaemin)FDA LinkGeneric 04/2010 - 02/2007
1	Sorbitol (Yal)FDA Link 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Midodrine (Midon)FDA LinkGeneric 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2021
1	hydroxyethyl methacrylate (HEMA)IBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2020

Therapy/Procedure

26	Percutaneous Coronary Intervention 09/2020 - 01/2005
17	Therapeutics 01/2021 - 06/2002
16	Drug-Eluting Stents 05/2022 - 01/2005
13	Stents 09/2020 - 09/2005
9	Catheter Ablation 12/2020 - 04/2011
3	Surgical Amputation (Amputations) 01/2021 - 03/2015
2	Cardiac Rehabilitation 12/2021 - 01/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2007 - 01/2005
1	Glycemic Control 04/2022
1	Secondary Prevention 01/2021
1	Limb Salvage 01/2021